Skip to content

Insider · CIK 0001366841

Jost Fischer

director

Files at AEON (AEON Biopharma, Inc.). First filing May 21, 2025, latest May 23, 2025.

In brief

Jost Fischer files SEC Form 4 as director at AEON (AEON Biopharma, Inc.). Since May 21, 2025, Jost Fischer has reported 2 open-market buys worth $85k and 0 open-market sells worth $0, the latest filed on May 23, 2025.

A track record needs three past buys with six months of prices behind them; Jost Fischer has 0, so none is measured yet.

The newest scored trade: bought $29k of AEON on May 21, 2025, filed May 23, 2025, scored 31 (weak).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
2 / 0
$85k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

AEON: AEON Biopharma, Inc.

AEONOct 9, 2026 · close 0.28

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
31Weak
AEONbuy
AEON Biopharma, Inc.
$29k
60,000 shares
+29%-
32Weak
AEONbuy
AEON Biopharma, Inc.
$55k
110,000 shares
+114%-

Transactions

Every row this insider has filed, 6 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 17, 2026AEON
AEON Biopharma, Inc.
AGrant or award
Class A Common Stock
+222,684$0.00$0489,469Jun 22, 2026
May 21, 2025AEON
AEON Biopharma, Inc.
POpen-market purchase
Class A Common Stock
+60,000$0.49$29k266,785May 23, 2025
May 21, 2025AEON
AEON Biopharma, Inc.
AGrant or award
Restricted Stock Unitsderivative
+308,641$0.00$0308,641May 23, 2025
May 19, 2025AEON
AEON Biopharma, Inc.
POpen-market purchase
Class A Common Stock
+50,000$0.50$25k146,785May 21, 2025
May 20, 2025AEON
AEON Biopharma, Inc.
POpen-market purchase
Class A Common Stock
+60,000$0.51$30k206,785May 21, 2025
Mar 19, 2024AEON
AEON Biopharma, Inc.
AGrant or award
Stock Optionderivative
+16,260$0.00$016,260Mar 21, 2024

Questions about Jost Fischer

Answered from the filings on this page, as of the latest one.

Is Jost Fischer buying or selling?

Not in the last 12 months. Jost Fischer's latest open-market trade on SEC Form 4 was bought $29k of AEON on May 21, 2025.

How did Jost Fischer's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jost Fischer has 0.

Where does Jost Fischer file Form 4?

Jost Fischer has filed Form 4 at AEON (AEON Biopharma, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jost Fischer: insider trades and track record | InsiderTell